Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Recent Stories

Teva Wins FDA Approval For Generic Epinephrine

After nearly two years, the U.S. Food & Drug Administration has finally approved the generic versions of the EpiPen produced by Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA).

Jon Najarian Sees Unusual Options Activity In JD.Com And Dicks Sporting Goods

On CNBC's "Fast Money Halftime Report", Jon Najarian spoke about unusually high options volume in JD.Com Inc(ADR) (NASDAQ: JD) and Dicks Sporting Goods Inc (NYSE:

Goldman Sachs: Newly Public Avalara Shares Hold 30% Upside Potential

Tax software maker Avalara Inc (NYSE: AVLR) made an initial public offering of 7.5 million shares at $24 each, with the shares priced on June 15.

What Is The Buffett Indicator?

Few voices on Wall Street are more respected than that of Berkshire Hathaway, Inc. (NYSE: BRK-A)(NYSE: BRK-B) CEO Warren Buffett.

Higher Prices At Kimberly Clark Are Behind JPMorgan's Higher Rating

Kimberly Clark Corp (NYSE: KMB)'s announcement that it's raising prices on a host of key items in North America triggered a sell-side upgrade Thursday. 

Goldman Sachs: Chinese Vehicle E-Commerce Platform Uxin Should Be Profitable By 2020

Uxin Ltd (ADR) (NASDAQ: UXIN), a Chinese e-commerce platform for used cars, won over a sell-side bull Thursday, with Goldman Sachs identifying three key strengths in the company.

Mid-Afternoon Market Update: Dow Rises Over 400 Points; SpartanNash Shares Plummet

Toward the end of trading Thursday, the Dow traded up 1.71 percent to 25,591.51 while the NASDAQ climbed 0.66 percent to 7,825.61. The S&P also rose, gaining 0.95 percent to 2,845.09.

These Analysts Love Tesla's Potential, But Balk At Its Valuation

Tesla Inc (NASDAQ: TSLA) has been the talk of the town on Wall Street in recent weeks, and analysts are weighing in on Tesla and CEO Elon Musk’s controversial proposa

Deere & Co's Q3 Earnings Preview

On Friday, Deere & Co (NYSE: DE) will report its last quarter's earnings. Here is Benzinga's take on the company's release.

Earnings and Revenue

Wall Street analysts see Deere & Co reporting earnings of $2.75 per share on sales of $9.21 billion.

Niche Brands Continue To Threaten The Mass Beauty Industry; Analyst Downgrades Coty

A near-term recovery for Coty Inc (NYSE: COTY) seems unlikely, according to a new analyst report.

The Analyst

Bank of America analyst Olivia Tong downgraded Coty from Buy to Underperform and lowered her price target from $16 to $10.

1 (877) 440-9464 (ZING) © Copyright Benzinga